Download PDF
Semin Reprod Med 2008; 26(1): 014-021
DOI: 10.1055/s-2007-992920
© Thieme Medical Publishers

Polycystic Ovary Syndrome in Asian Women

Ernest Hung Yu Ng1 , Pak Chung Ho1
  • 1Department of Obstetrics and Gynaecology, The University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China
Further Information

Publication History

Publication Date:
08 January 2008 (online)

    Permissions and Reprints

ABSTRACT

There is substantial heterogeneity of symptoms and signs among women with polycystic ovary syndrome (PCOS). In addition to different diagnostic criteria used, the ethnic background of women with PCOS may affect the clinical, hormonal, and metabolic characteristics of this condition. We present here studies related to the clinical, hormonal, and metabolic characteristics and response to the treatment of PCOS in Asia, which may be different from those in Western countries. It is important to take into consideration the ethnic background of patients in future studies related to PCOS.

KEYWORDS

Asian women - ethnic origin - polycystic ovary syndrome

REFERENCES

  • 1 Azziz R, Woods K S, Reyna R, Key T J, Knochenhauer E S, Yildiz B O. The prevalence and features of the polycystic ovary syndrome in an unselected population.  J Clin Endocrinol Metab. 2004;  89 2745-2749
    CrossrefPubMedGoogle Scholar
  • 2 Franks S. Polycystic ovary syndrome.  N Engl J Med. 1995;  333 853-861
    CrossrefPubMedGoogle Scholar
  • 3 The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group . Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.  Hum Reprod. 2004;  19 41-47
    CrossrefPubMedGoogle Scholar
  • 4 Adams J, Polson D W, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.  BMJ. 1986;  293 355-359
    CrossrefPubMedGoogle Scholar
  • 5 Balen A H, Laven J SE, Tan S L, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions.  Hum Reprod Update. 2003;  9 505-514
    CrossrefPubMedGoogle Scholar
  • 6 Taponen S, Ahonkallio S, Martikainen H et al.. Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 study.  Hum Reprod. 2004;  19 1083-1088
    CrossrefPubMedGoogle Scholar
  • 7 Rodin D A, Bano G, Bland J M, Taylor K, Nussey S S. Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women.  Clin Endocrinol (Oxf). 1998;  49 91-99
    CrossrefPubMedGoogle Scholar
  • 8 Ng E HY, Fong D YT, Yeung W SB, Ho P C. Effects of age on hormonal and ultrasound markers of ovarian reserve in Chinese women with proven fertility.  Hum Reprod. 2003;  18 2169-2174
    CrossrefPubMedGoogle Scholar
  • 9 Ng E HY, Chan C CW, Yeung W SB, Ho P C. Effect of age on ovarian stromal flow measured by three-dimensional ultrasound with power Doppler in Chinese women with proven fertility.  Hum Reprod. 2004;  19 2132-2137
    CrossrefPubMedGoogle Scholar
  • 10 Ng E HY, Chan C CW, Yeung W SB, Ho P C. Antral follicle count and follicle stimulating hormone concentration after clomiphene citrate challenge test in the prediction of ovarian response during in vitro fertilization treatment.  Hum Reprod. 2005;  20 1647-1654
    CrossrefPubMedGoogle Scholar
  • 11 Chan C CW, Ng E HY, Tang O S, Lee C P, Ho P C. The prevalence of polycystic ovary in Chinese women with a history of gestational diabetes.  Gynecol Endocrinol. 2006;  22 516-520
    CrossrefPubMedGoogle Scholar
  • 12 Yao L Q, Kuang J Q, Feng Y J, Yang D Z, Li L, Xu C J. Characterization of unilateral polycystic ovary compared with polycystic ovary syndrome.  Fertil Steril. 2006;  85 805-808
    CrossrefPubMedGoogle Scholar
  • 13 Zaidi J, Campbell S, Pittrof R et al.. Ovarian stromal blood flow in women with polycystic ovaries-a possible new marker for diagnosis?.  Hum Reprod. 1995;  10 1992-1996
    PubMedGoogle Scholar
  • 14 Agrawal R, Sladkevicius P, Engmann L et al.. Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries.  Hum Reprod. 1998;  13 651-655
    CrossrefPubMedGoogle Scholar
  • 15 Pairleitner H, Steiner H, Hasenoehrl G, Staudach A. Three-dimensional power Doppler sonography: imaging and quantifying blood flow and vascularization.  Ultrasound Obstet Gynecol. 1999;  14 139-143
    CrossrefPubMedGoogle Scholar
  • 16 Pan H A, Wu M H, Cheng Y C, Li C H, Chang F M. Quantification of Doppler signal in polycystic ovary syndrome using three-dimensional power Doppler ultrasonography: a possible new marker for diagnosis.  Hum Reprod. 2002;  17 201-206
    CrossrefPubMedGoogle Scholar
  • 17 Järvelä I Y, Mason H D, Sladkevicius P et al.. Characterization of normal and polycystic ovaries using three-dimensional power Doppler ultrasonography.  J Assist Reprod Genet. 2002;  19 582-590
    CrossrefPubMedGoogle Scholar
  • 18 Ng E HY, Chan C CW, Yeung W SB, Ho P C. Comparison of ovarian stromal flow measured by three-dimensional power Doppler ultrasound between fertile women with normal ovaries and infertile women with polycystic ovary syndrome.  Hum Reprod. 2005;  20 1881-1886
    CrossrefPubMedGoogle Scholar
  • 19 Carmina E, Koyama T, Chang L, Stanczyk F Z, Lobo R A. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?.  Am J Obstet Gynecol. 1992;  167 1807-1812
    PubMedGoogle Scholar
  • 20 Norman R J, Mahabeer S, Masters S. Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome.  Fertil Steril. 1995;  63 58-62
    PubMedGoogle Scholar
  • 21 Wijeyaratne C N, Balen A H, Barth J H, Belchetz P E. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome PCOS) among South Asians and Caucasians: is there a difference?.  Clin Endocrinol (Oxf). 2002;  57 343-350
    CrossrefPubMedGoogle Scholar
  • 22 Chen X, Yang D, Li L, Feng S, Wang L. Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome.  Hum Reprod. 2006;  21 2027-2032
    CrossrefPubMedGoogle Scholar
  • 23 Li L, Yang D, Chen X, Chen Y, Feng S, Wang L. Clinical and metabolic features of polycystic ovary syndrome.  Int J Gynaecol Obstet. 2007;  97 129-134
    CrossrefPubMedGoogle Scholar
  • 24 Ng E HY, Chan C CW, Ho P C. Are there differences in ultrasound parameters between women with polycystic ovaries only and with polycystic ovary syndrome?.  Eur J Obstet Gynecol Reprod Biol. 2006;  125 92-98
    CrossrefPubMedGoogle Scholar
  • 25 The ESHRE Capri Workshop . Female infertility: treatment options for complicated cases.  Hum Reprod. 1997;  12 1191-1196
    CrossrefPubMedGoogle Scholar
  • 26 Takahashi K, Uchida A, Yamasaki H, Ozaki T, Kitao M. Transvaginal ultrasonic assessment of the response to clomiphene citrate in polycystic ovarian syndrome.  Fertil Steril. 1994;  62 48-53
    PubMedGoogle Scholar
  • 27 Kondoh Y, Uemura T, Ishikawa M, Yokoi N, Hirahara F. Classification of polycystic ovary syndrome into three types according to response to human corticotropin-releasing hormone.  Fertil Steril. 1999;  72 15-20
    CrossrefPubMedGoogle Scholar
  • 28 Andoh K, Mizunuma H, Liu X, Kamijo T, Yamada K, Ibuki Y. A comparative study of fixed-dose, step-down, and low-dose step-up regimens of human menopausal gonadotropin for patients with polycystic ovary syndrome.  Fertil Steril. 1998;  70 840-846
    CrossrefPubMedGoogle Scholar
  • 29 Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanisms and implication for pathogenesis.  Endocr Rev. 1997;  18 774-800
    CrossrefPubMedGoogle Scholar
  • 30 Lord J M, Flight I HK, Norman R J. Metformin in polycystic ovary syndrome: systematic review and meta-analysis.  BMJ. 2003;  327 951-953
    PubMedGoogle Scholar
  • 31 Ng E HY, Wat W MS, Ho P C. Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial.  Hum Reprod. 2001;  16 1625-1631
    CrossrefPubMedGoogle Scholar
  • 32 Moll E, Bossuyt P M, Korevaar J C, Lambalk C B, van der Veen F. Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial.  BMJ. 2006;  332 1485-1489
    CrossrefPubMedGoogle Scholar
  • 33 Legro R S, Barnhart H X, Schlaff W D et al.. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome.  N Engl J Med. 2007;  356 551-566
    CrossrefPubMedGoogle Scholar
  • 34 Kiddy D S, Hamilton-Fairley D, Bush A et al.. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome.  Clin Endocrinol (Oxf). 1992;  36 105-111
    CrossrefPubMedGoogle Scholar
  • 35 Han L K, Takaku T, Li J, Kimura Y, Okuda H. Anti-obesity action of oolong tea.  Int J Obes Relat Metab Disord. 1999;  23 98-105
    CrossrefPubMedGoogle Scholar
  • 36 Kao Y H, Hiipakka R A, Liao S. Modulation of endocrine systems and food intake by green tea epigallocatechin gallate.  Endocrinology. 2000;  141 980-987
    CrossrefPubMedGoogle Scholar
  • 37 Chantre P, Lairon D. Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity.  Phytomedicine. 2002;  9 3-8
    CrossrefPubMedGoogle Scholar
  • 38 Dulloo A G, Duret C, Rohrer D et al.. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans.  Am J Clin Nutr. 1999;  70 1040-1045
    PubMedGoogle Scholar
  • 39 Yang T TC, Koo M WL. Hypocholesterolemic effects of Chinese tea.  Pharmacol Res. 1997;  35 505-512
    CrossrefPubMedGoogle Scholar
  • 40 Chan C CW, Koo M WL, Ng E HY, Tang O S, Yeung W SB, Ho P C. Effects of Chinese green tea on weight, hormonal and biochemical profiles in obese patients with polycystic ovary syndrome - a randomized placebo controlled trial.  J Soc Gynecol Investig. 2006;  13 63-68
    PubMedGoogle Scholar
  • 41 Imai K, Suga K, Nakachi K. Cancer-preventive effects of drinking green tea among a Japanese population.  Prev Med. 1997;  26 769-775
    CrossrefPubMedGoogle Scholar
  • 42 Wang D Z, Wang Z Q, Shi L Y. Treatment of polycystic ovary syndrome with Chinese drug longdan xiegan tang.  J Tradit Chin Med. 1988;  8 117-119
    PubMedGoogle Scholar
  • 43 Takahashi K, Kitao M. Effect of TJ-68 (shakuyaku-kanzo-to) on polycystic ovarian disease.  Int J Fertil Menopausal Stud. 1994;  39 69-76
    PubMedGoogle Scholar
  • 44 Sakai A, Kondo Z, Kamei K, Izumi S, Sumi K. Induction of ovulation by Sairei-to for polycystic ovary syndrome patients.  Endocr J. 1999;  46 217-220
    PubMedGoogle Scholar
  • 45 Ushiroyama T, Ikeda A, Sakai M et al.. Effects of unkei-to, an herbal medicine, on endocrine function and ovulation in women with high basal levels of luteinizing hormone secretion.  J Reprod Med. 2001;  6 451-456
    PubMedGoogle Scholar
  • 46 Xiao B. Chinese traditional medicine for induction of ovulation.  J Reprod Med. 2003;  12(Suppl 1) 1-8
    PubMedGoogle Scholar
  • 47 Farquhar C, Lilford R J, Marjoribanks J, Vandekerckhove P. Laparoscopic “drilling” by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.  Cochrane Database Syst Rev. 2005;  3 CD001122
    PubMedGoogle Scholar
  • 48 Wu X K, Su Y H, Zhang Z X. Wedge resection to improve insulin resistance in polycystic ovary syndrome: a study among Chinese women.  Br J Obstet Gynaecol. 1996;  103 822-825
    PubMedGoogle Scholar
  • 49 Zhu W, Li X, Chen X, Lin Z, Zhang L. Ovarian interstitial YAG-laser: an effective new method to manage anovulation in women with polycystic ovary syndrome.  Am J Obstet Gynecol. 2006;  195 458-463
    CrossrefPubMedGoogle Scholar

Ernest Hung Yu NgM.D. 

Department of Obstetrics and Gynaecology, The University of Hong Kong

6/F, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong

Email: nghye@hkucc.hku.hk